Paper41286754
Early aminophylline is a potential therapy for preventing bronchopulmonary dysplasia in premature infants: a retrospective study.
Tang L and 5 others. BMC Pediatr, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Early aminophylline is a potential therapy for preventing bronchopulmonary dysplasia in premature infants: a retrospective study. Papers, record 41286754. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41286754
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Early aminophylline is a potential therapy for preventing bronchopulmonary dysplasia in premature infants: a retrospective study.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aminophylline | Major topic |
| Bronchopulmonary Dysplasia | Major topic |
| Humans | |
| Retrospective Studies | |
| Infant, Newborn | |
| Infant, Premature | |
| Female | |
| Male | |
| Respiration, Artificial | |
| Incidence | |
| Gestational Age | |
| Oxygen Inhalation Therapy |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2023A04J2300 | Science and Technology Projects in Guangzhou | PubMed | ||
| 2022A1515012021 | Natural Science Foundation of Guangdong Province | PubMed |
Source PubMed
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26141482 | Neurodevelopmental Outcomes in Very Low Birth Weight Infants Using Aminophylline for the Treatment of Apnea. | Pediatr Neonatol | 2016 | https://conductscience.org/library/papers/26141482 | PubMed |
| 2 | 33121916 | Neurodevelopmental outcomes after neonatal caffeine therapy. | Semin Fetal Neonatal Med | 2020 | https://conductscience.org/library/papers/33121916 | PubMed |
| 3 | 33059799 | [Clinical guidelines for the diagnosis and treatment of feeding intolerance in preterm infants (2020)]. | Zhongguo Dang Dai Er Ke Za Zhi | 2020 | https://conductscience.org/library/papers/33059799 | PubMed |
| 4 | 24788885 | Theophylline improves lipopolysaccharide-induced alveolarization arrest through inflammatory regulation. | Mol Med Rep | 2014 | https://conductscience.org/library/papers/24788885 | PubMed |
| 5 | 36121807 | Comparative efficacy and safety of caffeine citrate and aminophylline in treating apnea of prematurity: A systematic review and meta-analysis. | PLoS One | 2022 | https://conductscience.org/library/papers/36121807 | PubMed |
| 6 | 31587528 | Impact of early caffeine therapy in preterm newborns on infant lung function. | Pediatr Pulmonol | 2020 | https://conductscience.org/library/papers/31587528 | PubMed |
| 7 | 32831996 | Prevention of Oxygen-Induced Inflammatory Lung Injury by Caffeine in Neonatal Rats. | Oxid Med Cell Longev | 2020 | https://conductscience.org/library/papers/32831996 | PubMed |
| 8 | 36532766 | Precision caffeine therapy for apnea of prematurity and circadian rhythms: New possibilities open up. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36532766 | PubMed |
| 9 | 35915341 | Effectiveness and safety of early versus late caffeine therapy in managing apnoea of prematurity among preterm infants: a retrospective cohort study. | Int J Clin Pharm | 2022 | https://conductscience.org/library/papers/35915341 | PubMed |
| 10 | 24399614 | Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity. | Paediatr Drugs | 2014 | https://conductscience.org/library/papers/24399614 | PubMed |
| 11 | 24479608 | Early caffeine therapy for prevention of bronchopulmonary dysplasia in preterm infants. | J Matern Fetal Neonatal Med | 2014 | https://conductscience.org/library/papers/24479608 | PubMed |
| 12 | 31473373 | Caffeine not associated with irritable behaviour in very low-birth-weight infants. | Early Hum Dev | 2019 | https://conductscience.org/library/papers/31473373 | PubMed |
| 13 | 33771081 | Prophylactic versus therapeutic caffeine for apnea of prematurity: a randomized controlled trial. | J Matern Fetal Neonatal Med | 2022 | https://conductscience.org/library/papers/33771081 | PubMed |
| 14 | 24932388 | Reducing the incidence of chronic lung disease in very premature infants with aminophylline. | Int J Prev Med | 2014 | https://conductscience.org/library/papers/24932388 | PubMed |
| 15 | 34199266 | Early High-Dose Caffeine Improves Respiratory Outcomes in Preterm Infants. | Children (Basel) | 2021 | https://conductscience.org/library/papers/34199266 | PubMed |
| 16 | 3606448 | An international classification of retinopathy of prematurity. II. The classification of retinal detachment. | Arch Ophthalmol | 1987 | https://conductscience.org/library/papers/3606448 | PubMed |
| 17 | 37791592 | Caffeine versus other methylxanthines for the prevention and treatment of apnea in preterm infants. | Cochrane Database Syst Rev | 2023 | https://conductscience.org/library/papers/37791592 | PubMed |
| 18 | 27526255 | Systematic review and meta-analysis of clinical outcomes of early caffeine therapy in preterm neonates. | Br J Clin Pharmacol | 2017 | https://conductscience.org/library/papers/27526255 | PubMed |
| 19 | 31077204 | Antioxidative effects of caffeine in a hyperoxia-based rat model of bronchopulmonary dysplasia. | Respir Res | 2019 | https://conductscience.org/library/papers/31077204 | PubMed |
| 20 | 3556038 | Neonatal necrotizing enterocolitis: pathogenesis, classification, and spectrum of illness. | Curr Probl Pediatr | 1987 | https://conductscience.org/library/papers/3556038 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41286754
GET https://conductscience.org/api/papers/v1/41286754/references?page=2